Wells Fargo Maintains Equal-Weight on HCA Healthcare, Raises Price Target to $395
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo has maintained its Equal-Weight rating on HCA Healthcare while raising the price target from $365 to $395, indicating a positive outlook on the stock.

October 22, 2024 | 3:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo has maintained its Equal-Weight rating on HCA Healthcare and increased the price target from $365 to $395, suggesting a positive outlook.
The increase in price target from $365 to $395 by Wells Fargo indicates a positive outlook on HCA Healthcare's stock. Maintaining the Equal-Weight rating suggests that while the stock is expected to perform well, it may not outperform the market significantly. This news is likely to have a positive short-term impact on HCA's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100